Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Is the treatment of multiple sclerosis headed in the wrong direction?
Natural, innate improvements in multiple sclerosis disability.
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.
Multiple sclerosis and glutamate excitotoxicity.
Acid-sensing ion channels: trafficking and synaptic function.
Secukinumab: first global approval.
Top 10 Research Questions Related to Physical Activity and Multiple Sclerosis.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
Extreme Stability of Chitotriosidase in Cerebrospinal Flulid makes it a Suitable Marker for Microglial Activation in Clinical Trials.
The nervous system's potential role in multiple sclerosis associated bone loss.
Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial.
[Neuromyelitis optica.]
Targeting the shift from m1 to m2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers.
Increasing age at disability milestones among MS patients in the MSBase Registry.
Type 1 immune response in progressive multiple sclerosis.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
[Prevention of multiple sclerosis: A realistic goal?]
Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.
Pages
« first
‹ previous
…
209
210
211
212
213
214
215
216
217
…
next ›
last »